Logo image of BKD

BROOKDALE SENIOR LIVING INC (BKD) Stock Fundamental Analysis

NYSE:BKD - New York Stock Exchange, Inc. - US1124631045 - Common Stock - Currency: USD

5.3  -0.01 (-0.19%)

After market: 5.35 +0.05 (+0.94%)

Fundamental Rating

1

We assign a fundamental rating of 1 out of 10 to BKD. BKD was compared to 108 industry peers in the Health Care Providers & Services industry. Both the profitability and financial health of BKD have multiple concerns. BKD has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

BKD had negative earnings in the past year.
BKD had a positive operating cash flow in the past year.
In the past 5 years BKD reported 4 times negative net income.
The reported operating cash flow has been mixed in the past 5 years: BKD reported negative operating cash flow in multiple years.
BKD Yearly Net Income VS EBIT VS OCF VS FCFBKD Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 200M -200M -400M

1.2 Ratios

BKD has a Return On Assets of -3.52%. This is comparable to the rest of the industry: BKD outperforms 42.99% of its industry peers.
BKD has a Return On Equity of -71.42%. This is in the lower half of the industry: BKD underperforms 73.83% of its industry peers.
BKD has a Return On Invested Capital (0.86%) which is in line with its industry peers.
Industry RankSector Rank
ROA -3.52%
ROE -71.42%
ROIC 0.86%
ROA(3y)-2.99%
ROA(5y)-2.3%
ROE(3y)-33.99%
ROE(5y)-26.04%
ROIC(3y)N/A
ROIC(5y)N/A
BKD Yearly ROA, ROE, ROICBKD Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -20 -40

1.3 Margins

With a Operating Margin value of 1.87%, BKD perfoms like the industry average, outperforming 48.60% of the companies in the same industry.
In the last couple of years the Operating Margin of BKD has declined.
BKD has a Gross Margin (25.68%) which is comparable to the rest of the industry.
In the last couple of years the Gross Margin of BKD has remained more or less at the same level.
Industry RankSector Rank
OM 1.87%
PM (TTM) N/A
GM 25.68%
OM growth 3Y53.94%
OM growth 5Y-9.99%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.22%
GM growth 5Y0.99%
BKD Yearly Profit, Operating, Gross MarginsBKD Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 10 -10 20

More info and screens

0

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), BKD is destroying value.
BKD has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
BKD Yearly Shares OutstandingBKD Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 50M 100M 150M
BKD Yearly Total Debt VS Total AssetsBKD Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2B 4B 6B 8B 10B

2.2 Solvency

Based on the Altman-Z score of -0.29, we must say that BKD is in the distress zone and has some risk of bankruptcy.
With a Altman-Z score value of -0.29, BKD is not doing good in the industry: 78.50% of the companies in the same industry are doing better.
A Debt/Equity ratio of 14.54 is on the high side and indicates that BKD has dependencies on debt financing.
BKD's Debt to Equity ratio of 14.54 is on the low side compared to the rest of the industry. BKD is outperformed by 85.98% of its industry peers.
Industry RankSector Rank
Debt/Equity 14.54
Debt/FCF N/A
Altman-Z -0.29
ROIC/WACC0.12
WACC7.01%
BKD Yearly LT Debt VS Equity VS FCFBKD Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 2B 4B 6B

2.3 Liquidity

A Current Ratio of 0.81 indicates that BKD may have some problems paying its short term obligations.
With a Current ratio value of 0.81, BKD is not doing good in the industry: 85.05% of the companies in the same industry are doing better.
BKD has a Quick Ratio of 0.81. This is a bad value and indicates that BKD is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 0.81, BKD is doing worse than 77.57% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.81
Quick Ratio 0.81
BKD Yearly Current Assets VS Current LiabilitesBKD Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 200M 400M 600M 800M 1B

More info and screens

3

3. Growth

3.1 Past

The earnings per share for BKD have decreased strongly by -61.40% in the last year.
BKD shows a small growth in Revenue. In the last year, the Revenue has grown by 4.63%.
Measured over the past years, BKD shows a decrease in Revenue. The Revenue has been decreasing by -7.82% on average per year.
EPS 1Y (TTM)-61.4%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%0%
Revenue 1Y (TTM)4.63%
Revenue growth 3Y-5.2%
Revenue growth 5Y-7.82%
Sales Q2Q%3.55%

3.2 Future

BKD is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 9.55% yearly.
BKD is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 0.44% yearly.
EPS Next Y11.02%
EPS Next 2Y11.29%
EPS Next 3Y9.55%
EPS Next 5YN/A
Revenue Next Year3.71%
Revenue Next 2Y3.98%
Revenue Next 3Y0.44%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
BKD Yearly Revenue VS EstimatesBKD Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 1B 2B 3B 4B 5B
BKD Yearly EPS VS EstimatesBKD Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 2 -2

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for BKD. In the last year negative earnings were reported.
Also next year BKD is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
BKD Price Earnings VS Forward Price EarningsBKD Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

68.22% of the companies in the same industry are more expensive than BKD, based on the Enterprise Value to EBITDA ratio.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 12.08
BKD Per share dataBKD EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y11.29%
EPS Next 3Y9.55%

More info and screens

0

5. Dividend

5.1 Amount

BKD does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

BROOKDALE SENIOR LIVING INC

NYSE:BKD (2/18/2025, 8:27:43 PM)

After market: 5.35 +0.05 (+0.94%)

5.3

-0.01 (-0.19%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)02-18 2025-02-18/amc
Earnings (Next)05-05 2025-05-05
Inst Owners107.63%
Inst Owner Change0.6%
Ins Owners3.14%
Ins Owner Change11.6%
Market Cap1.06B
Analysts73.33
Price Target7.04 (32.83%)
Short Float %4.29%
Short Ratio4.01
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-18.94%
Min EPS beat(2)-25.67%
Max EPS beat(2)-12.21%
EPS beat(4)1
Avg EPS beat(4)-23.91%
Min EPS beat(4)-84.2%
Max EPS beat(4)26.45%
EPS beat(8)4
Avg EPS beat(8)12.01%
EPS beat(12)5
Avg EPS beat(12)3.43%
EPS beat(16)7
Avg EPS beat(16)19.75%
Revenue beat(2)0
Avg Revenue beat(2)-1.1%
Min Revenue beat(2)-1.2%
Max Revenue beat(2)-1%
Revenue beat(4)0
Avg Revenue beat(4)-1.03%
Min Revenue beat(4)-1.2%
Max Revenue beat(4)-0.88%
Revenue beat(8)0
Avg Revenue beat(8)-0.78%
Revenue beat(12)0
Avg Revenue beat(12)-0.7%
Revenue beat(16)1
Avg Revenue beat(16)-1.18%
PT rev (1m)0%
PT rev (3m)-6.76%
EPS NQ rev (1m)-1.61%
EPS NQ rev (3m)-28.57%
EPS NY rev (1m)-0.68%
EPS NY rev (3m)-6.47%
Revenue NQ rev (1m)0.01%
Revenue NQ rev (3m)-0.3%
Revenue NY rev (1m)0.03%
Revenue NY rev (3m)-0.06%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.34
P/FCF N/A
P/OCF 7.02
P/B 3.6
P/tB 3.98
EV/EBITDA 12.08
EPS(TTM)-0.92
EYN/A
EPS(NY)-0.64
Fwd EYN/A
FCF(TTM)-0.3
FCFYN/A
OCF(TTM)0.75
OCFY14.24%
SpS15.56
BVpS1.47
TBVpS1.33
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -3.52%
ROE -71.42%
ROCE 1.08%
ROIC 0.86%
ROICexc 0.9%
ROICexgc 0.91%
OM 1.87%
PM (TTM) N/A
GM 25.68%
FCFM N/A
ROA(3y)-2.99%
ROA(5y)-2.3%
ROE(3y)-33.99%
ROE(5y)-26.04%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y54.5%
ROICexcg growth 5Y-15.52%
ROICexc growth 3Y55.62%
ROICexc growth 5Y-14.95%
OM growth 3Y53.94%
OM growth 5Y-9.99%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.22%
GM growth 5Y0.99%
F-Score5
Asset Turnover0.52
Health
Industry RankSector Rank
Debt/Equity 14.54
Debt/FCF N/A
Debt/EBITDA 10.17
Cap/Depr 58.1%
Cap/Sales 6.76%
Interest Coverage 0.24
Cash Conversion 35.92%
Profit Quality N/A
Current Ratio 0.81
Quick Ratio 0.81
Altman-Z -0.29
F-Score5
WACC7.01%
ROIC/WACC0.12
Cap/Depr(3y)58.42%
Cap/Depr(5y)86.44%
Cap/Sales(3y)7.11%
Cap/Sales(5y)9.44%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-61.4%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%0%
EPS Next Y11.02%
EPS Next 2Y11.29%
EPS Next 3Y9.55%
EPS Next 5YN/A
Revenue 1Y (TTM)4.63%
Revenue growth 3Y-5.2%
Revenue growth 5Y-7.82%
Sales Q2Q%3.55%
Revenue Next Year3.71%
Revenue Next 2Y3.98%
Revenue Next 3Y0.44%
Revenue Next 5YN/A
EBIT growth 1Y391.65%
EBIT growth 3Y45.93%
EBIT growth 5Y-17.03%
EBIT Next Year1851.8%
EBIT Next 3Y186.67%
EBIT Next 5YN/A
FCF growth 1Y75.07%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y607.78%
OCF growth 3Y-7.46%
OCF growth 5Y-4.4%